Shares of Teleflex Inc. TFX slipped 4.57% to $132.75 Friday, on what proved to be an all-around great trading session for the ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Teleflex vascular access (24% of sales) is a no-moat business, in our view. While Teleflex leads the market for central venous catheters, or CVC, tubes that are connected to veins and used to deliver ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Teleflex (TFX – Research Report). The company’s ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

RBC Capital downgraded Teleflex to Sector Perform, lowering the price target to $155 from $220, pointing to the company’s ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the ...